FOREIGN GROUPS ENTER VIETNAM PHARMACEUTICAL MARKET
Vietnamese pharmaceutical companies are gradually being outdone by foreign competitors. With a series of loosening policies published, Vietnam's pharmaceutical market is a lucrative piece of cake for foreign pharmaceutical companies to jump in.
Pharmaceuticals are supposed to be one of the three key sectors that investors consider most likely to invest money when contributing capital. Because the demand in this pharmaceutical industry is completely unaffected by economic stability or recession like other industries.
Moreover, Vietnam with a large population will be a potential market for foreign businesses. Since the beginning of the year until now, pharmaceutical companies and foreign investors have not missed any opportunity to participate in sales and cooperation deals with Vietnamese pharmaceutical companies in order to market share expansion.
In addition, Vietnam's pharmaceutical market from the beginning of the year has maintained an average growth rate of double digits. Therefore, Vietnam is still a potentially fertile market that foreign companies target.
The most significant factor affecting in 2020 is Vietnam's stability against the Covid-19 epidemic. With the ability to prevent, localize and quickly deal with outbreaks of Covid-19 in 2020 and early 2021. Vietnam's economy is stabilizing again and partly benefits when other countries are still struggling. anti-epidemic.
Recognizing the above major and minor issues, in the past years, especially in 2020, a lot of foreign investors / businesses have massively flocked to the Vietnamese market through many ways, buying shares. , build a new factory…
Abbot enters Vietnam's pharmaceutical industry
In August 2016, a company known to mothers and children for its wide range of dairy products, Abbot of the United States, completed all the procedures in the acquisition of a company specializing in the pharmaceutical sector. of Vietnam is Glomed Pharmaceuticals limited liability company. This is a large and well-known pharmaceutical company in the Vietnamese pharmaceutical market.
All details about this transaction are kept completely confidential. However, after completing the acquisition procedures for this pharmaceutical company, Abbot has become one of the top ten pharmaceutical companies in the production and distribution of pharmaceutical products in the Vietnamese market.
After this deal, Abbot has in hand two factories specializing in the production of Western medicines in Vietnam Singapore industrial park Binh Duong from Glomed. In addition, Abbot also owns a list of products including antibiotics, digestive drugs, respiratory and cardiovascular drugs, pain relievers, health and beauty drugs such as female physiological drugs, a group of products. OTC drugs in bulk.
Combined with a chain of more than 3000 employees and 20 years of experience in the Vietnamese market, Abbot will surely be known as a giant in the pharmaceutical industry and will become a serious competitor for pharmaceutical companies. Vietnam in the near future.
Not to mention Glomed is a very capable company, has been assessed by Vietnamreport as one of the 100 enterprises with the highest growth rate and is currently one of the top five drug brands in Vietnam. Up to now, Abbot has made plans based on the existing success of Glomed to ensure long-term development in the pharmaceutical field in Vietnam.
Japanese pharmaceutical company sets foot in Vietnam market
Before Abbot's acquisition of Glomed, in July 2016, Japanese pharmaceutical company Taisho Pharmaceutial Holdings, a subsidiary of Taisho Holdings, announced the completion of the acquisition of 24.5% of shares of Pharmaceutical Company. Hau Giang is the largest pharmaceutical enterprise on the stock exchange of Vietnam today. Until last year, Taisho officially dominated the largest pharmaceutical company in the Mekong Delta with over 51% capital.
In the past year, ASKA Japan Corporation also completed the acquisition of 25% of shares of Ha Tay Pharmaceutical Company, becoming the main shareholder of the company.
INTERNATIONAL COMPANIES CONTINUOUSLY INTO PHARMACEUTICAL INDUSTRY MARKET
Pharmaceutical group CFR International SPA transferred all 51.69% stake in Domesco Medical Import-Export Joint Stock Company after 6 years of holding to Abbott Laboratories (Chile) Holdco SPA. The transfer value at that time was estimated at 2,300 billion VND. In essence, this transaction is between member companies because since 2014, Abbott has taken ownership of CFR International SPA through a merger and acquisition transaction.
Stada Service Holding B.V and related people a month ago were allowed by the general meeting of shareholders of Pymepharco Joint Stock Company (PME) to increase the ownership rate to a maximum of 100% without a public bid. Just last week, this shareholder bought 4.5 million shares, equivalent to 380 billion VND to increase the ownership rate to approximately 76%. Although not much has changed since the deal, in fact, foreign partners are participating more deeply in this wave of acquisitions.
In parallel with the acquisition of shares of companies, foreign enterprises also cooperate with Vietnamese pharmaceutical companies to make the most of their available distribution channels.
A typical example of this is that in September, Sanofi Group, which is rated as one of the 20 largest pharmaceutical companies in the world, strengthened its strategic cooperation relationship with General Pharmaceutical Corporation. Vietnam Vinapharm.
The pharmaceutical industry will continue to grow at double-digit rates in the period 2020-2025 and reach $7.7 billion next year, according to data from Yuanta Securities Vietnam. The demand and level of payment for health care of the people is also increasing, while every year our country still has to import a large amount of medicine due to insufficient production supply. Last year this figure was about 3 billion USD and is expected to increase to 4.35 billion USD this year.
“Pharmaceutical is a specific field, it takes a lot of time to build a name and capture market share. Meanwhile, the majority of domestic pharmaceutical enterprises only produce drugs in generic form because the preparation level is still limited and there is not much potential to invest large costs in research and development of new drugs. Taking advantage of the existing advantages of enterprises to combine with scientific achievements, exclusive drug formulas of major companies in the world is an inevitable trend of Vietnam's pharmaceutical industry" - Ms. Ly Thi Hien, Head of Distribution Department. analysis of Yuanta Securities Vietnam Co., Ltd.
The entry of foreign companies into our country's pharmaceutical market will be an opportunity for enterprises to improve their competitiveness and create a driving force for the development of Vietnam's pharmaceutical industry. However, the downside is that if our companies cannot compete, it is very easy for the pharmaceutical market to fall into the hands of foreign enterprises.
The wet granulation process in two separate steps is mostly recommended and suitable for conventional equipment like the High-speed Mixer & Granulator, Fluid-bed Dryer & Granulator…
This single-step granulation process provides effervescent granules directly by granulating the acid and the alkaline materials together. It is possible to use only water as the granulating liquid, thus controlling the effervescent reaction to granulate, or using a nonreactive liquid, like absolute ethanol or isopropanol, but in this case, it is necessary to use a binder to get the agglomeration of the particles of the raw material. There are two type of equipment complying with this technology.
This dosage form is easier to administer, particularly helpful to patients, like children, who are not able to swallow capsules or tablets. However, the manufaturing of them is more complex than conventional forms, especially in selecting technology and processing equipment
The Covid-19 pandemic has posed many new challenges for pharmaceutical startups. What needs to be done to be able to survive and develop, especially during this period. The StartUs Insight newspaper based on the analytical research of "1745 famous startups in the pharmaceutical industry in 2020", found the most outstanding startups. To be able to turn challenges into opportunities, pharmaceutical companies have a "secret" for startups to survive the pandemic.
Inspecting tooling and press components for wear or defects could be the most important step in improving tablet quality. There are certain inspection points that are easy to overlook yet can cause significant tablet quality issues and limit tool life. Spend a little time checking the following items for wear or defects to quickly increase tablet quality and reduce tooling cost
The pharmaceutical industry follows the most stringent requirements for manufacturing processes and used equipment also must comply with good manufacturing practices (GMP). As drug development trends change, so do manufacturing processes, much of which can now be automated...
The COVID-19 health crisis has brought strong scientific impacts and advances, while also valuable lessons for businesses, organizations and countries around the world:
At the Poison Control Center, Bach Mai Hospital has received many cases of poisoning due to the abuse of drug paracetamol to treat COVID-19. Therefore, people should be careful about medicines spread of unknown origin on social networks, before using any medicine that requires a doctor's opinion, not to use it on their own.
From August 1, 2021, businesses can look up the status of certificate of origin form D on the internet. At the same time, enterprises that import consignments of drugs and medicinal ingredients imported from Red Luong must present the original power of attorney, circulation permit and product testing sheet...
Maintaining production, delivery on time and keeping commitments to clients is a remarkable effort, demonstrating Tien Tuan's prestige, internal strength and high competitiveness.
According to the Vietnamese Embassy in India, this is a suggestion made by the big players in the Indian pharmaceutical industry during a trade and investment promotion meeting chaired by Vietnamese Ambassador to India - Mr. Pham Sanh Chau.
With the union of Tien Tuan company and the timely leadership of the manager board, the shipment has been successfully exported to customers in the Asian.
On the purpose of providing to valued clients & readers the latest Vietnamese pharmaceutical news and international pharma production trends, update state-of-the-art features, global technology, we periodically send to you the monthly bulletin.
What do the terms 'containment' and 'isolation' mean in the pharmaceutical industry? Why must all cancer drug production line adopt this system?
Common vocabularies and definition in Pharmaceutical Validation.
This pilot batch of Sputnik V vaccine brings hope to Vietnam's community vaccination campaign.
Before 2020, the concept of Ultra Low Temperature Freezers (ULT) was very little known, except in the medical and related industries. But when Pfizer announced that their vaccines required storage at -70°C, a world reeling from the pandemic took a big interest in the concept of "deep cryo" preservation.
Hand sanitizers are over-the-counter (OTC) drug products. Symptoms of headache, nausea, and dizziness may occur after applying alcohol-based hand sanitizer to the skin. These symptoms can be caused by inhaling vapors from hand sanitizer, by exposure to confined spaces or places with poor air circulation...The US Food and Drug Administration (FDA) has just released a warning about washing hand in this Pandemic.
According to WHO estimates, nearly $40 billion is lost each year to counterfeit products. Not only economic losses, counterfeit drugs also increase health risks, lead to drug recalls, and tarnish the brand image of the struggling pharmaceutical industry.
One of the measures the industry took to overcome this challenge was to implement pharmaceutical serialization to protect the consumers.
Coating becomes an essential technology in pharmaceutical. During last 25 years, the coating layer has obviously undergone some changes. More improvement in coating technologies have been made to enhance higher quality of drug and its manufacturing operation.
There is idea supposed that the traditional pharmaceutical industry is quite conservative and so a multitude of reasons ranging from regulation to financial resources can be given to reason for the delay in the adoption of new technologies. However, we will certainly witness dramatic and innovative changes in the pharmaceutical industry in the coming years as Industry 4.0 is becoming a global technological revolution.
The European Commission has approved the lung cancer drug as an add-on treatment for adults diagnosed early enough for the tumour to be surgically removed, and who have a mutation of the EGFR gene.
With production on pause and millions of COVID-19 vaccine doses in limbo, Johnson & Johnson has been hustling to right the ship at CDMO Emergent BioSolutions' troubled Baltimore manufacturing facility. Now, it looks as if relief is in sight.
The pharmaceutical Industry is sensitive to Covid-19 but is slowly recovering. The Covid-19 pandemic is a great challenge for the entire population and manufacturing industries, especially the pharmaceutical industry, in case of strong community spread. However, at the present, the health care target is the main goal and an essential expenditure for the people. Demand for Medicines will only be temporarily delayed in the short term and will gradually recover.
(According to Vietnamreport) Top 10 prestigious pharmaceutical companies are ranked based on scientific and objective principles. Companies are evaluated and ranked based on 3 main criteria: (1) Financial capacity shown in the latest year's financial statements; (2) Media reputation is assessed by Media Coding method - encoding articles about the company on influential media channels; (3) Survey of stakeholders was carried out in October and November 2020.
The COVID-19 pandemic occured in the end of 2019 and officially broke out in early 2020, leading to many complicated consequences, directly affecting public health and the world economy.
It seemed that the pharmaceutical industry would be the main development industry during the Covid pandemic, but on the contrary, the Pharmaceutical industry as well as other industries have suffered a lot of damage from Covid.
The Seminar “How to build pharmaceutical factory complying to EU-GMP?” held by Tien Tuan on August 18th 2017 at Meeting Room No. 2 – Saigon Exhibition and Convention Center , Ho Chi Minh City was a successful event and the topic gathered much attention from industrial specialists and experts from Vietnam pharmaceutical industry.
In order to assist pharmaceutical companies in Vietnam to catch up with the latest development in processing technology, Tien Tuan would like to invite you to come and discuss with us at seminars 1) Telstar – Isolator and 2) Natoli with complete solution for puch, die and tableting. The seminars will be organized at Ha Noi International Exhibition Center – 91 Tran Hung Dao st., Hoan Kiem District, Ha Noi